Stock comparison
IDEXX Laboratories
Dr. Reddy's Laboratories Limited
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
RDY
Dr. Reddy's Laboratories Limited
Market cap
$11.32B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | RDY | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 57C | IDXX |
| Benjamin Graham | 80A | 72B | IDXX |
| Philip Fisher | 75B | 61C | IDXX |
| Peter Lynch | 71B | 55C | IDXX |
| Joel Greenblatt | 83C | 46D | IDXX |
| Charlie Munger | 87A | 49D | IDXX |
| Terry Smith | 84A | 45D | IDXX |
Side-by-side metrics
| Metric | IDXX | RDY |
|---|---|---|
| Market cap | $44.12B | $11.32B |
| P/E (TTM) | 39.0x | 26.0x |
| EV/EBIT | 31.6x | 24.0x |
| ROIC (TTM) | 40.66% | 8.07% |
| Gross margin | 62.05% | 52.77% |
| Net margin | 24.63% | 12.76% |
| Revenue CAGR 5y | 7.56% | 13.31% |
| EPS CAGR 5y | 10.79% | 17.36% |
| Debt / Equity | 0.7x | 0.2x |
| Dividend yield | 0.0% | 0.6% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- ROIC (TTM)40.66%vs 8.07%+80%
- Market cap$44.12Bvs $11.32B+74%
- Net margin24.63%vs 12.76%+48%
- Gross margin62.05%vs 52.77%+15%
RDY leads on
- Dividend yield0.6%vs 0.0%+100%
- Debt / Equity0.2xvs 0.7x+70%
- Revenue CAGR 5y13.31%vs 7.56%+43%
- EPS CAGR 5y17.36%vs 10.79%+38%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.